Please use this identifier to cite or link to this item: http://hdl.handle.net/2445/132806
Title: Combination of exercise training and erythropoietin prevents cancer-induced alterations.
Author: Pin, Fabrizio
Busquets Rius, Sílvia
Toledo Soler, Miriam
Camperi, Andrea
López-Soriano, Francisco J.
Costelli, Paola
Argilés Huguet, Josep Ma.
Penna, Fabio
Keywords: Càncer
Biologia
Bioquímica
Eritropoetina
Caquèxia
Distròfia muscular
Cancer
Biology
Biochemistry
Erythropoietin
Cachexia
Muscular dystrophy
Issue Date: 7-Aug-2015
Publisher: Impact Journals
Abstract: Cancer cachexia is a syndrome characterized by loss of skeletal muscle mass, inflammation, anorexia and anemia, contributing to patient fatigue and reduced quality of life. In addition to nutritional approaches, exercise training (EX) has been proposed as a suitable tool to manage cachexia. In the present work the effect of mild exercise training, coupled to erythropoietin (EPO) administration to prevent anemia, has been tested in tumor-bearing mice. In the C26 hosts, acute exercise does not prevent and even worsens muscle wasting. Such pattern is prevented by EPO co-administration or by the adoption of a chronic exercise protocol. EX and EPO co-treatment spares oxidative myofibers from atrophy and counteracts the oxidative to glycolytic shift, inducing PGC-1α. LLC hosts are responsive to exercise and their treatment with the EX-EPO combination prevents the loss of muscle strength and the onset of mitochondrial ultrastructural alterations, while increases muscle oxidative capacity and intracellular ATP content, likely depending on PGC-1α induction and mitophagy promotion. Consistently, muscle-specific PGC-1α overexpression prevents LLC-induced muscle atrophy and Atrogin-1 hyperexpression. Overall, the present data suggest that low intensisty exercise can be an effective tool to be included in combined therapeutic approaches against cancer cachexia, provided that anemia is coincidently treated in order to enhance the beneficial action of exercise.
Note: Reproducció del document publicat a: https://doi.org/10.18632/oncotarget.6439
It is part of: Oncotarget, 2015, vol. 6, num. 41, p. 43202-43215
URI: http://hdl.handle.net/2445/132806
Related resource: https://doi.org/10.18632/oncotarget.6439
ISSN: 1949-2553
Appears in Collections:Articles publicats en revistes (Bioquímica i Biomedicina Molecular)

Files in This Item:
File Description SizeFormat 
658944.pdf1.82 MBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons